Microplastics and nanoplastics in haemodialysis waters: Emerging threats to be in our radar.

Filtration Kidney disease Plasticisers Reverse osmosis Risk Water

Journal

Environmental toxicology and pharmacology
ISSN: 1872-7077
Titre abrégé: Environ Toxicol Pharmacol
Pays: Netherlands
ID NLM: 9612020

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 13 06 2023
revised: 07 08 2023
accepted: 18 08 2023
medline: 13 9 2023
pubmed: 22 8 2023
entrez: 21 8 2023
Statut: ppublish

Résumé

Microplastics are present in the environment, in drinking water, in human blood and there is evidence of nanoplastics in tap water. The objective of this work was to analyze the possibility of hemodialysis patients being contaminated by micro and nanoplastics (MNPs) during dialysis treatment. The motivation for this investigation is the fact that hemodialysis patients use about 300-600 L of drinking water per week, which may be contaminated by MNPs. A literature review, a field investigation in a London hospital and an estimation of MNPs intake in patients were carried out. The results showed potential points of risk of contamination of patients by MNPs in hemodialysis. It was also estimated that for a filtration efficiency of 99 % for MNPs, the amount of microplastics that can penetrate the kidneys of patients is 0.0021-3768 particles/week. The assessment concludes that hemodialysis patients are at high risk of MNP contamination.

Identifiants

pubmed: 37604358
pii: S1382-6689(23)00195-3
doi: 10.1016/j.etap.2023.104253
pii:
doi:

Substances chimiques

Microplastics 0
Plastics 0
Drinking Water 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104253

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Robson S Passos (RS)

Environmental Management Coordination and Environmental Technology and Bioprocesses Research Group, Federal Institute of Education, Science and Technology of Pernambuco, Av. Prof. Luís Freire, 500 - Cidade Universitária, Recife 50740-545, Brazil; Department of Civil, Environmental and Geomatic Engineering, University College London, London WC1E 6BT, United Kingdom. Electronic address: robsonpassos@recife.ifpe.edu.br.

Andrew Davenport (A)

UCL Department of Renal Medicine, Royal Free Hospital, University College London, London NW3 2PF, United Kingdom.

Rosa Busquets (R)

Department of Civil, Environmental and Geomatic Engineering, University College London, London WC1E 6BT, United Kingdom; Department of Chemical and Pharmaceutical Sciences, Kingston University London, Penrhyn road, Kingston upon Thames KT1 2EE, United Kingdom.

Clare Selden (C)

Institute for Liver & Digestive Health, Royal Free Campus, UCL Medical School, Rowland Hill St, London NW3 2PF, United Kingdom.

Luiz B Silva (LB)

Labour Analysis Laboratory, Federal University of Paraíba, João Pessoa Campus I, Cidade Universitaria, 58051-900, Brazil.

J Santos Baptista (JS)

Associated Laboratory for Energy, Transports and Aeronautics (LAETA/PROA), Faculty of Engineering of University of Porto - FEUP, Rua Dr Roberto Frias, s/n, 4200-465 Porto, Portugal.

Damià Barceló (D)

Water and Soil Quality Research Group, Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA-CSIC), Jordi Girona 1826, Barcelona 08034, Spain.

Luiza C Campos (LC)

Department of Civil, Environmental and Geomatic Engineering, University College London, London WC1E 6BT, United Kingdom. Electronic address: l.campos@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH